Platform

Built on insights derived from comprehensive
pan-cancer PTM studies and leveraging the latest in AI technology, our platform offers unparalleled insights into protein-defined tumor subtypes, cancer-specific pathways, and post-translational modifications (PTMs) across diverse cancer types.

Our Platform

Features

First-in-Class Generative AI model

250,000 expert curated protein annotation

8 cancer types

State-dependent protein conformations

Capabilities

Full cell-specific proteome simulations

  • Condition-relevant post-translational variants

  • Conformational ensembles of target proteins

Conditional de novo protein synthesis

  • Complete candidate protein sequence generation

  • Controlled environmental specificity by cell subtype, disease state, and topological domain

Request full demo